pharmaceutical investing Hemispherx to Distribute Second Lot of Ampligen for use in Multiple Indications in Argentina, the United States and Europe
pharmaceutical investing Hemispherx Biopharma Announces Extension of Rintatolimod European Early Access Program (EAP) to Pancreatic Cancer Patients
Steadright Files Q1 Interim FS and MD&A / Moroccan Site and Cancellation of Crushing & Grinding Equipment Share Purchase Agreement With Possible Renegotiation
